Bangladesh vs Trinidad and Tobago: Reported number of people receiving antiretroviral therapy
Bangladesh
8,352
in 2025
Trinidad and Tobago
7,442
in 2025
Bangladesh rank
93rd
Trinidad and Tobago rank
96th
Reported number of people receiving antiretroviral therapy over time
- Bangladesh
- Trinidad and Tobago
How they compare
Bangladesh currently reports 8,352 against 7,442 in Trinidad and Tobago, a difference of 910.
That makes Bangladesh's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Trinidad and Tobago ahead.
Bangladesh ranks 93rd and Trinidad and Tobago ranks 96th of 143 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.7 | 1,442 | 1,369 | Trinidad and Tobago |
| 2010s | 1,648 | 6,288 | 4,640 | Trinidad and Tobago |
| 2020s | 6,046 | 7,234 | 1,188 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported number of people receiving antiretroviral therapy, Bangladesh or Trinidad and Tobago?
- Bangladesh, at 8,352 against 7,442 in Trinidad and Tobago as of 2025.
- What is the difference in reported number of people receiving antiretroviral therapy between Bangladesh and Trinidad and Tobago?
- 910, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Trinidad and Tobago?
- 26 years are reported by both, from 2000 to 2025.
- How do Bangladesh and Trinidad and Tobago rank globally for reported number of people receiving antiretroviral therapy?
- Bangladesh ranks 93rd and Trinidad and Tobago ranks 96th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Reported number of people receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.